clopidogrel + prasugrel
Phase 1Terminated 1 views this week 0 watching💤 Quiet
Interest: 21/100
21
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Acute Coronary Syndromes
Conditions
Acute Coronary Syndromes
Trial Timeline
Oct 1, 2009 → Dec 1, 2010
NCT ID
NCT01107899About clopidogrel + prasugrel
clopidogrel + prasugrel is a phase 1 stage product being developed by Daiichi Sankyo for Acute Coronary Syndromes. The current trial status is terminated. This product is registered under clinical trial identifier NCT01107899. Target conditions include Acute Coronary Syndromes.
What happened to similar drugs?
20 of 20 similar drugs in Acute Coronary Syndromes were approved
Approved (20) Terminated (4) Active (0)
✅Modification of Prasugrel based on a biological assay + prasugrel / clopidogrelDaiichi SankyoApproved
Hype Score Breakdown
Clinical
6
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01107899 | Phase 1 | Terminated |
Competing Products
20 competing products in Acute Coronary Syndromes